Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2013
11/26/2013US8592344 Pesticidal compositions comprising 4,5-dihydroxyindan-1-one
11/26/2013US8592197 Functional influenza virus-like particles (VLPs)
11/26/2013US8592196 Modified influenza virus
11/26/2013US8592163 Method of determining immune enhancement of virus infectivity using Fc receptor-transfected cell lines
11/26/2013US8592152 Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy
11/26/2013US8591943 Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors
11/26/2013US8591918 Mycobacterial mutants inducing IL-12
11/26/2013US8591917 Ganglioside based vaccine compositions for subcutaneous administration
11/26/2013US8591916 Flavivirus vaccine vector against influenza virus
11/26/2013US8591915 Plant-derived vaccines against respiratory syncytial virus
11/26/2013US8591914 Influenza hemagglutinin and neuraminidase variants
11/26/2013US8591913 Methods of decreasing adipose tissue
11/26/2013US8591910 Chemically programmable immunity
11/26/2013US8591909 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
11/26/2013US8591908 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis B and the producing method and use thereof
11/26/2013US8591907 Hypoallergenic variants of the major allergen from Betula verrucosa pollen
11/26/2013US8591906 Immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis
11/26/2013US8591905 Nicotine immunonanotherapeutics
11/26/2013US8591903 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation
11/26/2013US8591901 Antibodies to TGF-β
11/26/2013US8591900 Anti-CD40 antibodies
11/26/2013US8591899 Diagnosis of Bacillus anthracis infection based on detection of bacterial secreted biomarkers
11/26/2013US8591898 Treatment of interstitial cystitis
11/26/2013US8591897 Anti-ERBB2 antibody adjuvant therapy
11/26/2013US8591896 Chemokine receptor binding polypeptides
11/26/2013US8591895 Combinations for the treatment of diseases involving cell proliferation
11/26/2013US8591894 Humanized antibodies that sequester amyloid beta peptide
11/26/2013US8591893 Paratope and epitope of anti-mortalin antibody
11/26/2013US8591892 FTY720 increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell death
11/26/2013US8591891 Monoclonal antibodies against ANGPTL4
11/26/2013US8591890 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/26/2013US8591889 Human monoclonal antibodies specific for CD22
11/26/2013US8591888 Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders
11/26/2013US8591887 EPHA2 as a therapeutic target for cancer
11/26/2013US8591886 Combination therapies employing GITR binding molecules
11/26/2013US8591885 Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
11/26/2013US8591881 Chimeric Newcastle disease viruses and uses thereof
11/26/2013US8591863 Compositions against cancer antigen LIV-1 and uses thereof
11/26/2013US8591862 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
11/26/2013CA2718802C Recombinant nucleic acids comprising regions of ad6
11/26/2013CA2618374C Trimeric collagen scaffold antibodies
11/26/2013CA2615918C Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
11/26/2013CA2511538C Immunostimulatory combinations
11/26/2013CA2482744C Hiv envelope-cd4 complexes and hybrids
11/26/2013CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
11/26/2013CA2448971C Chimeric flavivirus vectors
11/26/2013CA2443223C Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/26/2013CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013CA2334850C Novel methods and interferon deficient substrates for the propagation of viruses
11/21/2013WO2013173820A2 Bispecific scfv immunofusion (bif)
11/21/2013WO2013173745A1 Monoclonal antibodies to macrophage stimulating protein
11/21/2013WO2013173697A1 Orally dissolving thin films containing allergens and methods of making and use
11/21/2013WO2013173582A1 Hepatitis c virus neutralizing antibody
11/21/2013WO2013173542A1 Methods for treating cancer with notch2/3 antibodies
11/21/2013WO2013173443A1 Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
11/21/2013WO2013173410A2 Affinity peptides toward infliximab
11/21/2013WO2013173393A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013WO2013173391A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013WO2013173364A2 Lingo-2 antagonists for treatment of conditions involving motor neurons
11/21/2013WO2013173348A1 Cross-reactive antibodies against dengue virus and uses thereof
11/21/2013WO2013173256A2 New and improved influenza vaccines
11/21/2013WO2013173076A1 Methods and compositions for generating and using allogeneic suppressor cells
11/21/2013WO2013172961A1 Compositions and methods for the diagnosis and treatment of tumor
11/21/2013WO2013172951A1 Methods for treatment of gastric cancer
11/21/2013WO2013172933A1 Ethnic gene profile of genes involved in angiogenesis may predict regional bevacizumab efficacy difference in gastric cancer
11/21/2013WO2013172927A1 Compositions and methods of vaccination
11/21/2013WO2013172923A1 Uses of antagonists of hyaluronan signaling
11/21/2013WO2013172379A1 Novel antibody and application thereof
11/21/2013WO2013172358A1 Functional compound, molecular assembly containing functional compound, composition containing molecular assembly, kit, and use of molecular assembly, composition or kit
11/21/2013WO2013171661A2 Adjuvant formulations and methods
11/21/2013WO2013171296A1 Diagnostic and treatment of sarcoidosis
11/21/2013WO2013171289A1 Combination of cd37 antibodies with further agents
11/21/2013WO2013171287A1 Combination of cd37 antibodies with ice (ifosfamide, carboplatin, etoposide)
11/21/2013WO2013171268A1 Allergen variants
11/21/2013WO2013171236A1 Fish vaccine
11/21/2013WO2013171055A1 Method for the in vitro maturation of dendritic cells.
11/21/2013WO2013170779A1 Pharmaceutical composition comprising anti-vegf antibody
11/21/2013WO2013170777A1 Use of anti-vefg antibody
11/21/2013WO2013170735A1 Method for treating and/or preventing lung injury
11/21/2013WO2013170367A1 Methods and uses for proprotein convert ase subtilisin kexin 9 (pcsk9) inhibitors
11/21/2013WO2013170365A1 Compositions of sparc polypeptide and grp78, and methods and uses thereof for sensitizing cancer cells
11/21/2013WO2013170305A1 Cellular vaccine and method of inducing an immune response in a subject
11/21/2013WO2013158276A8 Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
11/21/2013WO2013149219A3 Fully human antibodies that bind to vegfr2
11/21/2013WO2013142449A9 Treatment for chronic pain syndromes
11/21/2013WO2013129935A4 Use of a particulate immunomodulator in cancer therapy
11/21/2013WO2013122513A3 Nanobodies which bind to the chlamydia trachomatis antigen and method for inhibiting infection caused by chlamydia trachomatis
11/21/2013WO2013084147A3 Antibodies for epidermal growth factor receptor 3 (her3)
11/21/2013WO2013054307A3 Antibodies and methods for wnt pathway-related diseases
11/21/2013US20130310545 Inhibitors of Branched-Chain-Aminotransferase-1 (BCAT1) for the Treatment of Brain Tumors
11/21/2013US20130309309 Crystalline anti-htnfalpha antibodies
11/21/2013US20130309273 Thermostable Vaccine Compositions and Methods of Preparing Same
11/21/2013US20130309271 Method for Producing a Vaccine for the Treatment of Cancer
11/21/2013US20130309269 Methods for Producing Yeast-Based Vaccines
11/21/2013US20130309268 Compositions including transfer factor derived from eggs
11/21/2013US20130309267 Cancer immunotherapy compositions and methods of use
11/21/2013US20130309265 Yeast-Based Therapeutic for Chronic Hepatitis C Infection
11/21/2013US20130309263 Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
11/21/2013US20130309261 Hypoallergenic polypeptides for the treatment of house dust mite allergy
11/21/2013US20130309260 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 1823